2013;8:213–220.
194.UzielY,HashkesPJ,KassemE,etal.Theuseof
naproxeninthetreatmentofchildrenwith
rheumaticfever.JPediatr.2000;137:269–271.
195.HashkesPJ,TauberT,SomekhE,etal.
Naproxenasanalternativetoaspirinforthe
treatmentofarthritisofrheumaticfever:a
randomizedtrial.JPediatr.2003;143:399–401.
196.GenelF,ArslanogluS,UranN,etal.
Sydenham'schorea:clinicalfindingsand
comparisonoftheefficaciesofsodiumvalproate
andcarbamazepineregimens.BrainDev.
2002;24:73–76.
197.DaoudAS,ZakiM,ShakirR,etal.Effectiveness
ofsodiumvalproateinthetreatmentof
Sydenham'schorea.Neurology.1990;40:1140–
1141.
198.PenaJ,MoraE,CardozoJ,etal.Comparisonof
theefficacyofcarbamazepine,haloperidoland
valproicacidinthetreatmentofchildrenwith
Sydenham'schorea:clinicalfollow-upof18
patients.ArqNeuropsiquiatr.2002;60:374–377.
199.HarelL,ZechariaA,StraussbergR,etal.
Successfultreatmentofrheumaticchoreawith
carbamazepine.PediatrNeurol.2000;23:147–
151.
200.BarashJ,MargalithD,MatitiauA.
Corticosteroidtreatmentinpatientswith
Sydenham'schorea.PediatrNeurol.
2005;32:205–207.
201.CardosoF,MaiaD,CunninghamMC,etal.
Treatmentofsydenhamchoreawith
corticosteroids.MovDisord.2003;18:1374–
1377.
202.PazJA,SilvaCAA,Marques-DiasMJ.
Randomizeddouble-blindstudywithprednisone
inSydenham'schorea.PediatrNeurol.
2006;34:264–269.
203.GarveyMA,ZinderLA,LeitmanSF,etal.
TreatmentofSydenham'schoreawith
intravenousimmunoglobulin,plasmaexchange
orprednisone.JChildNeurol.2005;20:424–
429.
204.WalkerAR,TaniLY,ThompsonJA,etal.
Rheumaticchorea:relationshiptosystemic
manifestationsandresponsetocorticosteroids.J
Pediatr.2007;151:679–683.
205.FuscoC,UcchinoV,FrattiniD,etal.Acuteand
chroniccorticosteroidtreatmentoftenpatients
withparalyticformofSydenham'schorea.EurJ
PaediatrNeurol.2012;16:373–378.
206.SwedoSE,LeonardHL,SchapiroMB,etal.
Sydenham'schorea:physicalandpsychological
symptomsofstvitusdance.Pediatrics.
1993;91:706–713.
207.ThataiD,TuriZG.Currentguidelinesforthe
treatmentofpatientswithrheumaticfever.
Drugs.1999;57:545–555.
208.FeinsteinAR,SpagnuoloM,GillFA.Rebound
phenomenoninacuterheumaticfever.1.
Incidenceandsignificance.YaleJBiolMed.
1961;33:259–278.
209.CarapetisJR.Rheumaticheartdiseasein
developingcountries.NEnglJMed.
2007;357:439–441.
210.MarijonE,MirabelM,CelermajeDSr,etal.
Rheumaticheartdisease.Lancet.2012;379:953–
964.
211.MotaCCC.Rheumaticfeverinthe21stcentury.
CardiolYoung.2003;13:491–494.
212.AmericanAcademyofPediatrics.Groupa
streptococcalinfections.PickeringLK,Baker
CJ,LongSS,McMillanJA.RedBook:2006
ReportoftheCommitteeonInfectiousDiseases.
27thed.AmericanAcademyofPediatrics:Elk
GroveVillage,IL;2006:610–620.
213.PochicheoME.Astreptococcal
tonsillopharyngitiscost-effectivetreatment.Ann
EmergMed.1995;25:390–403.
214.BisnoAL.Acutepharyngitisetiologyand
diagnosis.Pediatrics.1996;97:949–954.